Lv1
40 积分 2026-02-27 加入
Cancer interception with KRAS inhibitors in preclinical models of pancreatic ductal adenocarcinoma
2天前
已完结
KRAS mutation coupled with p53 loss is sufficient to induce ovarian carcinosarcomas in mice
8天前
已完结
Molecular Genetics of Colorectal Cancer
8天前
已完结
KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy of CLDN18.2-targeted therapy
19天前
已完结
皖公网安备34019202002308
